{"url": "https://web.archive.org/web/20180706181656/https://www.wsj.com/articles/drugmakers-call-experimental-alzheimers-drug-study-outcome-positive-1530897640", "text": "Two drugmakers said they had \u201cpositive\u201d results from a midstage study of an experimental Alzheimer\u2019s drug, offering signs a medicine could finally disrupt the disease\u2019s memory-robbing course, though experts said it was too soon to say the drug marks a real advance.\n\nThe news drove up the stocks of the companies, Boston biotech Biogen Inc. and Japan\u2019s Eisai Co., by double-digit percentages on Friday while raising the hopes of caregivers and doctors.\n\n...", "images": ["https://web.archive.org/web/20180706181656im_/https://m.wsj.net/video/20180702/070218chinatariffs/070218chinatariffs_167x94.jpg", "https://web.archive.org/web/20180706181656im_/https://m.wsj.net/video/20180706/070618tourbalance_f3/070618tourbalance_f3_167x94.jpg", "https://web.archive.org/web/20180706181656im_/https://s.wsj.net/mktg/12for12_dollar_orange_165x28.png", "https://web.archive.org/web/20180706181656im_/https://s.wsj.net/public/resources/images/B3-AZ382_0629WA_C_20180629164459.jpg", "https://web.archive.org/web/20180706181656im_/https://m.wsj.net/video/20180706/060718thairescue1/060718thairescue1_167x94.jpg", "https://web.archive.org/web/20180706181656im_/https://m.wsj.net/video/20180703/070318seib/070318seib_167x94.jpg", "https://web.archive.org/web/20180706181656im_/https://images.wsj.net/im-17152/social", "https://web.archive.org/web/20180706181656im_/https://s.wsj.net/public/resources/images/B3-BA536_pw0706_C_20180705170916.jpg", "https://web.archive.org/web/20180706181656im_/https://s.wsj.net/public/resources/images/B3-BA573_tariff_C_20180705215041.jpg", "https://web.archive.org/web/20180706181656im_/https://m.wsj.net/video/20180704/050718thaicave2/050718thaicave2_167x94.jpg", "https://web.archive.org/web/20180706181656im_/https://images.wsj.net/im-16967?width=111&height=62", "https://web.archive.org/web/20180706181656im_/https://images.wsj.net/im-17112?width=111&height=62"], "top_img": "https://web.archive.org/web/20180706181656im_/https://images.wsj.net/im-17152/social", "keywords": [], "authors": ["Daniela Hernandez", "Peter Loftus", "Daniela.Hernandez Wsj.Com", "Peter.Loftus Dowjones.Com"], "canonical_link": "https://web.archive.org/web/20180706181656/https://www.wsj.com/articles/drugmakers-call-experimental-alzheimers-drug-study-outcome-positive-1530897640", "title": "Drugmakers Call Experimental Alzheimer\u2019s Drug Study Outcome Positive", "meta_data": {"viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "dj.asn": "i-07b7", "user.type": "nonsubscriber", "user.exp": "default", "page.section": "Article", "page.content.type": "Article", "page.content.format": "responsive", "og": {"type": "article", "title": "Drugmakers Call Experimental Alzheimer\u2019s Drug Study Outcome Positive", "description": "Biogen and Japan\u2019s Eisai said they had \u201cpositive\u201d results from a midstage study of an experimental Alzheimer\u2019s drug, offering signs a medicine could finally disrupt the disease\u2019s memory-robbing course, though experts said it was too soon to say the drug marks a real advance.", "url": "https://web.archive.org/web/20180706181656/https://www.wsj.com/articles/drugmakers-call-experimental-alzheimers-drug-study-outcome-positive-1530897640", "image": {"identifier": "https://web.archive.org/web/20180706181656im_/https://images.wsj.net/im-17152/social", "width": 900, "height": 471}, "locale": "en_US", "site_name": "WSJ"}, "page.content.source": "WSJ Online", "article.template": "snippet", "page.site": "wsj", "page.site.product": "WSJ", "page.region": "asia", "article.id": "SB11840705988313394737504584330761700636796", "article.type": "U.S. News", "article.type.display": "U.S.", "article.access": "paid", "article.origheadline": "Drugmakers Call Experimental Alzheimer\u2019s Drug Study Outcome Positive", "article.headline": "Drugmakers call experimental Alzheimer\u2019s drug study outcome positive", "article.summary": "Biogen and Japan\u2019s Eisai said they had \u201cpositive\u201d results from a midstage study of an experimental Alzheimer\u2019s drug, offering signs a medicine could finally disrupt the disease\u2019s memory-robbing course, though experts said it was too soon to say the drug marks a real advance.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB11840705988313394737504584330761700636796&headline=Drugmakers%20call%20experimental%20Alzheimer%u2019s%20drug%20study%20outcome%20positive&weburl=http://www.wsj.com/articles/SB11840705988313394737504584330761700636796", "al": {"ios": {"url": "wsj://launch?articleid=SB11840705988313394737504584330761700636796&headline=Drugmakers%20call%20experimental%20Alzheimer%u2019s%20drug%20study%20outcome%20positive&weburl=http://www.wsj.com/articles/SB11840705988313394737504584330761700636796"}}, "article.page": "US", "article.section": "US", "article.published": "2018-07-06T17:20:00.000Z", "article.updated": "2018-07-06T17:20:00.000Z", "article.created": "2018-07-06T17:20:00.000Z", "author": "Daniela Hernandez and Peter Loftus", "keywords": "alzheimer\u2019s, biogen, drug, eisai, phase 2, preliminary, stocks, study, topline results,Eisai,4523.TO,JP:4523,Biogen,BIIB,Axovant Sciences,AXON,Eli Lilly,LLY,Pfizer,PFE,AstraZeneca,AZN.LN,Geoffrey Porges,Lon S. Schneider,alzheimer's disease,biotechnology,political,general news,dementia,health,medical conditions,mental disorders,sciences,humanities,pharmaceuticals,health care,life sciences", "cXenseParse": {"wsj-keywords": "alzheimer\u2019s, biogen, drug, eisai, phase 2, preliminary, stocks, study, topline results,Eisai,4523.TO,JP:4523,Biogen,BIIB,Axovant Sciences,AXON,Eli Lilly,LLY,Pfizer,PFE,AstraZeneca,AZN.LN,Geoffrey Porges,Lon S. Schneider,alzheimer's disease,biotechnology,political,general news,dementia,health,medical conditions,mental disorders,sciences,humanities,pharmaceuticals,health care,life sciences", "wsj-primary-inset": "image", "poptart": {"image": "https://si.wsj.net/public/resources/images/S1-AQ015_ALZHEI_D_20180706130533.jpg"}, "candybar": {"image": "https://si.wsj.net/public/resources/images/S1-AQ015_ALZHEI_E_20180706130533.jpg"}}, "news_keywords": "alzheimer\u2019s, biogen, drug, eisai, phase 2, preliminary, stocks, study, topline results,Eisai", "description": "Biogen and Japan\u2019s Eisai said they had \u201cpositive\u201d results from a midstage study of an experimental Alzheimer\u2019s drug, offering signs a medicine could finally disrupt the disease\u2019s memory-robbing course, though experts said it was too soon to say the drug marks a real advance.", "article": {"word_count": 829, "image_count": 1, "internal_link_count": 8, "publisher": "https://www.facebook.com/wsj"}, "robots": "noarchive,noodp", "language": "en-US", "twitter": {"title": "Drugmakers Call Experimental Alzheimer\u2019s Drug Study Outcome Positive", "description": "Biogen and Japan\u2019s Eisai said they had \u201cpositive\u201d results from a midstage study of an experimental Alzheimer\u2019s drug, offering signs a medicine could finally disrupt the disease\u2019s memory-robbing course, though experts said it was too soon to say the drug marks a real advance.", "image": {"identifier": "https://images.wsj.net/im-17152/social", "alt": "Drugmakers call experimental Alzheimer\u2019s drug study outcome positive"}, "card": "summary_large_image", "creator": "@danielas_bot", "site": "@WSJ", "domain": "wsj.com"}, "fb": {"app_id": 368513495882, "pages": 8304333127}, "cx_shield": "{\"campaign\":10,\"placement\":\"cx-snippetad\",\"tag\":\"default\",\"type\":\"personalized\"}", "referrer": "always"}, "movies": [], "publish_date": null, "source": "https://web.archive.org", "summary": ""}